Signant Health Partners with Propeller Health

Published on: 

Applied Clinical Trials

Signant Health has announced a partnership to connect TrialMax to Propeller Health’s digital health platform for asthma and chronic obstructive pulmonary disease. The partnership will help drive patient adherence to inhaled medications by enabling accurate time tracking of patients’ medication use events alongside their eDiary data within a single electronic Clinical Outcome Assessment platform.  

To learn more, click here.